Stock (Symbol) |
Johnson & Johnson (JNJ) |
Stock Price |
$112 |
Sector |
| Healthcare |
Data is as of |
| May 2, 2016 |
Expected to Report |
| Jul 12 – Jul 18 |
Company Description |
Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Company’s primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Company’s subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Company’s research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom. Source: Thomson Financial |
Sharek’s Take |
One Year Chart |
JNJ was having a tough time last year as profits were hurt from the strong dollar. But now we will get earlier comparisons as profit growth estimates for the next 4 qtrs are -2%, 11%, 10% and 2%. J&J has beaten the street the past 4 qtrs as well. 2016’s profit estimate got bumped up from $6.52 to $6.60, 2017’s increased by more than a dime to $7.01. The Estimated Long-Term Growth Rate is just 6%, I prefer 10%. |
Fair Value |
JNJ currently sells for 17x earnings, which is my Fair Value. Upside doesn’t seem great but the dollar has weakened lately and that could boost profit estimates in the coming qtrs. |
Bottom Line |
Johnson & Johnson is in my opinion the most conservative stock for investors who want growth. With an estimated long-term growth rate of 6% a year in addition to a 3% yield, the estimated total return is 9% a year. Not bad considering CDs aren’t paying squat. JNJ ranks 15th of 35 stocks in the Conservative Portfolio Power Rankings. |
Power Rankings |
Growth Stock Portfolio
N/AAggressive Growth Portfolio N/AConservative Stock Portfolio 15 of 35 |

Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Company’s primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Company’s subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Company’s research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom. Source: Thomson Financial
JNJ was having a tough time last year as profits were hurt from the strong dollar. But now we will get earlier comparisons as profit growth estimates for the next 4 qtrs are
JNJ currently sells for 17x earnings, which is my Fair Value. Upside doesn’t seem great but the dollar has weakened lately and that could boost profit estimates in the coming qtrs.
Johnson & Johnson is in my opinion the most conservative stock for investors who want growth. With an estimated long-term growth rate of 6% a year in addition to a 3% yield, the estimated total return is 9% a year. Not bad considering CDs aren’t paying squat. JNJ ranks 15th of 35 stocks in the